Skip to main content

Human Atrial Natriuretic Peptide in Active Acromegaly: Effects on Hormonal, Metabolic, Hemodynamic, and Renal Parameters

  • Conference paper
Endocrinology of the Heart

Abstract

Patients with active acromegaly are characterized by increased plasma volume, sodium retention, increased renal plasma flow and increased glomerular filtration rate [2] as well as hyperinsulinemia and insulin resistance [1]. Moreover, prevalence of hypertension is increased in active acromegaly [4]. Therefore, it appeared worthy of examination whether effects of human atrial natriuretic peptide (human ANF — (99–126), hANP) or any impairment of hANP action might contribute to the pathophysiology of active acromegaly.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Althoff PH, Schmidt K, Hofmeister-Wagner WD, Knigge H, Rosak C, Jungmann E, Schöffling K (1987) Glukosetoleranz unter verschiedenen Pharmakotherapien der Akromegalie — differente Einflüsse von Bromocriptin und einem Somatostatin-Analogon. Akt Endokr Stoffw 8: 193

    Google Scholar 

  2. Falkhed T, Sjögren B (1964) Extracellular fluid volume and renal function in pituitary insufficiency and acromegaly. Acta Endocrinol 46: 80–88

    Google Scholar 

  3. Haak T, Jungmann E, Hannappel B, Schöffling K (1988) Zur Wirkung des humanen atrialen natriuretischen Peptides auf die Glucosetoleranz bei gesunden Probanden. Coll endocrinol südwestdtsch Arbeitsgruppen, Mainz

    Google Scholar 

  4. Hayward RP, Emanuel RW, Nabarro JDN (1986) Acromegalic heart disease: Influence of treatment of the acromegaly on the heart. Quart J Med 237: 41–58

    Google Scholar 

  5. Kühn M, Ammon HPT, Verspohl EJ (1988) Atrial natriuretic peptide acts via specific receptors on cGMP system of rat abstract islets without affecting insulin release. Diabetologia 31: 511A

    Google Scholar 

  6. Richards AM, Nicholls MG, Espiner EA, Ikram H, Yandle TG, Joyce SL, Cullens MM (1985) Effects of alpha-human atrial natriuretic peptide in essential hypertension. Hypertension 7: 812–817

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Jungmann, E., Schirmer, U., Haak, T., Scheuermann, EH., Schöffling, K. (1989). Human Atrial Natriuretic Peptide in Active Acromegaly: Effects on Hormonal, Metabolic, Hemodynamic, and Renal Parameters. In: Kaufmann, W., Wambach, G. (eds) Endocrinology of the Heart. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83858-3_54

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83858-3_54

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-51409-1

  • Online ISBN: 978-3-642-83858-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics